147 related articles for article (PubMed ID: 22512445)
1. Heparin--a key drug in the treatment of the circulatory degenerative diseases: controlling its action with polymers.
Szczubiałka K; Kamiński K; Zasada K; Karewicz A; Nowakowska M
Curr Pharm Des; 2012; 18(18):2591-606. PubMed ID: 22512445
[TBL] [Abstract][Full Text] [Related]
2. [Anticoagulation of the extracorporeal circuit in chronic hemodialysis].
Ryckelynck JP; Chouraqui D; Lobbedez T
Nephrologie; 1998; 19(4):223-5. PubMed ID: 9675763
[TBL] [Abstract][Full Text] [Related]
3. Use of protamine to rapidly reverse anticoagulant effect of unfractionated heparin in patients undergoing percutaneous coronary intervention.
Patel AA; White CM; Coleman CI
Conn Med; 2007 Feb; 71(2):93-5. PubMed ID: 17393902
[No Abstract] [Full Text] [Related]
4. Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial.
Arsenault KA; Paikin JS; Hirsh J; Dale B; Whitlock RP; Teoh K; Young E; Ginsberg JS; Weitz JI; Eikelboom JW
J Thorac Cardiovasc Surg; 2012 Oct; 144(4):944-950.e3. PubMed ID: 22743176
[TBL] [Abstract][Full Text] [Related]
5. Heparin-Mimicking Polymers: Synthesis and Biological Applications.
Paluck SJ; Nguyen TH; Maynard HD
Biomacromolecules; 2016 Nov; 17(11):3417-3440. PubMed ID: 27739666
[TBL] [Abstract][Full Text] [Related]
6. Heparin based polyurethanes: A state-of-the-art review.
Zia F; Zia KM; Zuber M; Tabasum S; Rehman S
Int J Biol Macromol; 2016 Mar; 84():101-11. PubMed ID: 26666430
[TBL] [Abstract][Full Text] [Related]
7. [Reversal for heparins and new anticoagulant treatments].
Kortchinsky T; Vigué B; Samama CM
Ann Fr Anesth Reanim; 2013 Jan; 32(1):37-49. PubMed ID: 23273505
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
Lepor NE
Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621
[TBL] [Abstract][Full Text] [Related]
9. Does Routine Reversal of Heparin With Protamine Sulphate in Patients Undergoing Carotid Endarterectomy Reduce Bleeding Complications Without Leading to Increased Thromboembolic Complications?
Lynch NP; Kavanagh EG
Eur J Vasc Endovasc Surg; 2016 Jan; 51(1):150. PubMed ID: 26482510
[No Abstract] [Full Text] [Related]
10. Heparin and low-molecular-weight heparin.
Gray E; Mulloy B; Barrowcliffe TW
Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
[TBL] [Abstract][Full Text] [Related]
11. Low-dose heparin during extracorporeal membrane oxygenation treatment in adults.
Yeo HJ; Kim DH; Jeon D; Kim YS; Cho WH
Intensive Care Med; 2015 Nov; 41(11):2020-1. PubMed ID: 26271907
[No Abstract] [Full Text] [Related]
12. Approaches to prevent bleeding associated with anticoagulants: current status and recent developments.
Kalathottukaren MT; Haynes CA; Kizhakkedathu JN
Drug Deliv Transl Res; 2018 Aug; 8(4):928-944. PubMed ID: 28741113
[TBL] [Abstract][Full Text] [Related]
13. Alteplase for Acute Ischemic Stroke after Heparin Reversal with Protamine: A Case Report and Review.
Fontaine GV; Smith SM
Pharmacotherapy; 2017 Oct; 37(10):e103-e106. PubMed ID: 28741720
[TBL] [Abstract][Full Text] [Related]
14. Sulfated polysaccharide heparin used as carrier to load hydrophobic lappaconitine.
Sun W; Saldaña MD; Fan L; Zhao Y; Dong T; Jin Y; Zhang J
Int J Biol Macromol; 2016 Mar; 84():275-80. PubMed ID: 26706841
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.
Skagerlind MSE; Stegmayr BG
Eur J Clin Pharmacol; 2018 Mar; 74(3):267-274. PubMed ID: 29198062
[TBL] [Abstract][Full Text] [Related]
16. [Heparin in surgery and artificial circulation: pro and contra. Is there an alternative?].
Roĭtman EV; Dement'eva II; Meshcheriakov AV
Anesteziol Reanimatol; 1997; (6):65-9. PubMed ID: 9511253
[No Abstract] [Full Text] [Related]
17. Intraoperative heparin anticoagulation and its reversal.
Wakefield TW; Stanley JC
Semin Vasc Surg; 1996 Dec; 9(4):296-302. PubMed ID: 8958606
[No Abstract] [Full Text] [Related]
18. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.
Hirsh J; Warkentin TE; Raschke R; Granger C; Ohman EM; Dalen JE
Chest; 1998 Nov; 114(5 Suppl):489S-510S. PubMed ID: 9822059
[No Abstract] [Full Text] [Related]
19. Anticoagulant efficacy of solid oral formulations containing a new heparin derivative.
Park JW; Jeon OC; Kim SK; Al-Hilal TA; Moon HT; Kim CY; Byun Y
Mol Pharm; 2010 Jun; 7(3):836-43. PubMed ID: 20349950
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation and reversal paradigms: is too much of a good thing bad?
Levy JH; Tanaka KA
Anesth Analg; 2009 Mar; 108(3):692-4. PubMed ID: 19224768
[No Abstract] [Full Text] [Related]
[Next] [New Search]
